
Hermetica Superfood Encyclopedia
Legacy index-continuity record: the score and narrative are provisional and must not be represented as validated or human-approved.
Review flags: AWAITING_SEMANTIC_VALIDATION
Aphanizomenon Flos-Aquae (AFA) is a blue-green algae containing phenylethanolamine and phenylethylamine compounds that enhance dopamine activity in the brain. This nutrient-dense cyanobacteria supports cognitive function and immune system health through its concentration of vitamins, minerals, and bioactive compounds.

Reported Benefits (Provisional)
Origin & History

Aphanizomenon Flos-Aquae (AFA) is a type of blue-green algae found in freshwater lakes, notably Klamath Lake in Oregon. It is harvested and dried to preserve its nutritional content, often sold in powdered or capsule form.
Research Narrative (Provisional)
Several observational studies suggest cognitive and immune benefits. More rigorous RCTs are needed to establish definitive health claims.
Preparation & Dosage
Dosage guidance is withheld because the publication gate has not recorded adequate support for this profile.
Nutritional Profile
- High in phycocyanin, a powerful antioxidant. - Contains essential fatty acids. - Rich in vitamins B12, C, and E.
Reported Mechanism (Provisional)
AFA contains phenylethylamine (PEA) and phenylethanolamine compounds that cross the blood-brain barrier and stimulate dopamine release in the brain's reward pathways. The algae's high concentration of B-vitamins, particularly B12 and folate, supports neurotransmitter synthesis and methylation processes. Its polysaccharides and phycocyanin compounds modulate immune cell activity by enhancing natural killer cell function and cytokine production.
Clinical Narrative (Provisional)
Limited human studies have examined AFA supplementation, with most research consisting of small pilot trials and observational studies. One study of 20 adults showed improved attention and mood scores after 6 weeks of 1.5g daily AFA supplementation. Animal studies demonstrate enhanced memory formation and immune marker improvements, but large-scale randomized controlled trials in humans are lacking. Current evidence is preliminary and requires more rigorous clinical validation.
Also Known As
Research updates — and 25% off your first order
Join our list for source-aware wellness education, review-state updates, and product news — and unlock 25% off your first Hermetica order. Educational content is not medical advice. No spam, unsubscribe anytime.







